Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis
Respirology2022Vol. 27(3), pp. 202–208
Citations Over TimeTop 10% of 2022 papers
Claudio Macaluso, Cristina Boccabella, Maria Kokosi, Nishanth Sivarasan, Vasileios Kouranos, Peter M. George, George Margaritopoulos, Philip L. Molyneaux, Felix Chua, Toby M. Maher, Gísli Jenkins, Andrew G. Nicholson, Sujal R. Desai, Anand Devaraj, Athol U. Wells, Elisabetta Renzoni, Carmel Stock
Abstract
Worsening in FVC and DLCO at 1 year, including a marginal decline in FVC ≥ 5% and DLCO ≥ 10%, is predictive of markedly reduced survival in fHP.
Related Papers
- → Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease(2018)92 cited
- → Effect of mycophenolate sodium in scleroderma-related interstitial lung disease(2011)71 cited
- → Pulmonary function tests in systemic sclerosis-associated interstitial lung disease: new directions and future prospects(2021)1 cited
- → POS1287 KL6 AND IL-18 LEVELS ARE NEGATIVELY CORRELATED WITH RESPIRATORY FUNCTION TESTS AND ILD EXTENT ASSESSED ON HRCT IN PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE (SSC-ILD)(2023)
- → Circulating Biomarkers and Disease Activity in Systemic Sclerosis-Associated Interstitial Lung Disease(2023)